Literature DB >> 18350256

Analysis of RAB27A gene in griscelli syndrome type 2: novel mutations including a deletion hotspot.

Setareh Mamishi1, Mohammad Hossein Modarressi, Babak Pourakbari, Banafshe Tamizifar, Fatemeh Mahjoub, Alireza Fahimzad, Soheila Alyasin, Mohamad Hassan Bemanian, Amir Ali Hamidiyeh, Mohammad Reza Fazlollahi, Mahmoud Reza Ashrafi, Anna Isaeian, Ghamartaj Khotaei, Mehdi Yeganeh, Nima Parvaneh.   

Abstract

INTRODUCTION: Griscelli syndrome type 2 is an autosomal recessive disorder characterized by pigmentary dilution and occurrence of acute phases of hemophagocytosis. The disease is caused by mutations in RAB27A gene, coding a small GTPase involved in terminal phases of cytotoxic granule/melanosome exocytosis.
MATERIALS AND METHODS: We describe the result of mutation analysis among nine patients from seven non-related Persian families. We present four novel mutations including a deletion hot spot (514del 5).
CONCLUSION: This hot spot is flanked by "direct repeats" of nucleotides, which are previously shown to be associated with areas of recurrent small deletions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18350256     DOI: 10.1007/s10875-008-9192-5

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  30 in total

1.  Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome.

Authors:  G Ménasché; E Pastural; J Feldmann; S Certain; F Ersoy; S Dupuis; N Wulffraat; D Bianchi; A Fischer; F Le Deist; G de Saint Basile
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

2.  Accelerated phase in partial albinism with immunodeficiency (Griscelli syndrome): genetics and stem cell transplantation in a 2-month-old girl.

Authors:  F A Baumeister; D Stachel; F Schuster; I Schmid; M Schaller; H Wolff; M Weiss; B H Belohradsky
Journal:  Eur J Pediatr       Date:  2000 Jan-Feb       Impact factor: 3.183

3.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

4.  Cloning, mapping and characterization of the human RAB27A gene.

Authors:  T Tolmachova; J S Ramalho; J S Anant; R A Schultz; C M Huxley; M C Seabra
Journal:  Gene       Date:  1999-10-18       Impact factor: 3.688

Review 5.  Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis.

Authors:  Gael Ménasché; Jérôme Feldmann; Alain Fischer; Geneviève de Saint Basile
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

6.  561del4 defines a novel small deletion hotspot in the interferon-gamma receptor 1 chain.

Authors:  S Rosenzweig; S E Dorman; J Roesler; J Palacios; M Zelazko; S M Holland
Journal:  Clin Immunol       Date:  2002-01       Impact factor: 3.969

7.  Molecular cloning and characterization of rab27a and rab27b, novel human rab proteins shared by melanocytes and platelets.

Authors:  D Chen; J Guo; T Miki; M Tachibana; W A Gahl
Journal:  Biochem Mol Med       Date:  1997-02

8.  Partial albinism with immunodeficiency (Griscelli syndrome).

Authors:  C Klein; N Philippe; F Le Deist; S Fraitag; C Prost; A Durandy; A Fischer; C Griscelli
Journal:  J Pediatr       Date:  1994-12       Impact factor: 4.406

9.  Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1).

Authors:  Gaël Ménasché; Chen Hsuan Ho; Ozden Sanal; Jérôme Feldmann; Ilhan Tezcan; Fügen Ersoy; Anne Houdusse; Alain Fischer; Geneviève de Saint Basile
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

10.  Evidence that Griscelli syndrome with neurological involvement is caused by mutations in RAB27A, not MYO5A.

Authors:  Yair Anikster; Marjan Huizing; Paul D Anderson; Diana L Fitzpatrick; Aharon Klar; Eva Gross-Kieselstein; Yackov Berkun; Gila Shazberg; William A Gahl; Haggit Hurvitz
Journal:  Am J Hum Genet       Date:  2002-06-07       Impact factor: 11.025

View more
  8 in total

1.  Mutation analysis and prenatal diagnosis of a family with Griscelli syndrome type 2: two novel mutations in the RAB27A gene.

Authors:  Patra Yeetong; Kanya Suphapeetiporn; Vorasuk Shotelersuk
Journal:  World J Pediatr       Date:  2017-08       Impact factor: 2.764

2.  Novel 47.5-kb deletion in RAB27A results in severe Griscelli Syndrome Type 2.

Authors:  Lisa M Vincent; Fred Gilbert; Jennifer I DiPace; Carla Ciccone; Thomas C Markello; Andrew Jeong; Heidi Dorward; Wendy Westbroek; William A Gahl; James B Bussel; Marjan Huizing
Journal:  Mol Genet Metab       Date:  2010-06-10       Impact factor: 4.797

3.  Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis.

Authors:  Hassan Abolhassani; Fatemeh Kiaee; Marzieh Tavakol; Zahra Chavoshzadeh; Seyed Alireza Mahdaviani; Tooba Momen; Reza Yazdani; Gholamreza Azizi; Sima Habibi; Mohammad Gharagozlou; Masoud Movahedi; Amir Ali Hamidieh; Nasrin Behniafard; Mohammamd Nabavi; Mohammad Hassan Bemanian; Saba Arshi; Rasol Molatefi; Roya Sherkat; Afshin Shirkani; Reza Amin; Soheila Aleyasin; Reza Faridhosseini; Farahzad Jabbari-Azad; Iraj Mohammadzadeh; Javad Ghaffari; Alireza Shafiei; Arash Kalantari; Mahboubeh Mansouri; Mehrnaz Mesdaghi; Delara Babaie; Hamid Ahanchian; Maryam Khoshkhui; Habib Soheili; Mohammad Hossein Eslamian; Taher Cheraghi; Abbas Dabbaghzadeh; Mahmoud Tavassoli; Rasoul Nasiri Kalmarzi; Seyed Hamidreza Mortazavi; Sara Kashef; Hossein Esmaeilzadeh; Javad Tafaroji; Abbas Khalili; Fariborz Zandieh; Mahnaz Sadeghi-Shabestari; Sepideh Darougar; Fatemeh Behmanesh; Hedayat Akbari; Mohammadreza Zandkarimi; Farhad Abolnezhadian; Abbas Fayezi; Mojgan Moghtaderi; Akefeh Ahmadiafshar; Behzad Shakerian; Vahid Sajedi; Behrang Taghvaei; Mojgan Safari; Marzieh Heidarzadeh; Babak Ghalebaghi; Seyed Mohammad Fathi; Behzad Darabi; Saeed Bazregari; Nasrin Bazargan; Morteza Fallahpour; Alireza Khayatzadeh; Naser Javahertrash; Bahram Bashardoust; Mohammadali Zamani; Azam Mohsenzadeh; Sarehsadat Ebrahimi; Samin Sharafian; Ahmad Vosughimotlagh; Mitra Tafakoridelbari; Maziar Rahimi; Parisa Ashournia; Anahita Razaghian; Arezou Rezaei; Setareh Mamishi; Nima Parvaneh; Nima Rezaei; Lennart Hammarström; Asghar Aghamohammadi
Journal:  J Clin Immunol       Date:  2018-10-09       Impact factor: 8.317

4.  History of primary immunodeficiency diseases in iran.

Authors:  Asghar Aghamohammadi; Mostafa Moin; Nima Rezaei
Journal:  Iran J Pediatr       Date:  2010-03       Impact factor: 0.364

Review 5.  Familial hemophagocytic lymphohistiocytosis: a model for understanding the human machinery of cellular cytotoxicity.

Authors:  Elena Sieni; Valentina Cetica; Elena Mastrodicasa; Daniela Pende; Lorenzo Moretta; Gillian Griffiths; Maurizio Aricò
Journal:  Cell Mol Life Sci       Date:  2011-10-12       Impact factor: 9.207

6.  Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis.

Authors:  Bianca Tesi; Kristina Lagerstedt-Robinson; Samuel C C Chiang; Eya Ben Bdira; Miguel Abboud; Burcu Belen; Omer Devecioglu; Zehra Fadoo; Allen E J Yeoh; Hans Christian Erichsen; Merja Möttönen; Himmet Haluk Akar; Johanna Hästbacka; Zuhre Kaya; Susana Nunes; Turkan Patiroglu; Magnus Sabel; Ebru Tugrul Saribeyoglu; Tor Henrik Tvedt; Ekrem Unal; Sule Unal; Aysegul Unuvar; Marie Meeths; Jan-Inge Henter; Magnus Nordenskjöld; Yenan T Bryceson
Journal:  Genome Med       Date:  2015-12-18       Impact factor: 11.117

7.  Griscelli Syndrome Type 2 Sine Albinism: Unraveling Differential RAB27A Effector Engagement.

Authors:  Yuta Ohishi; Sandra Ammann; Vahid Ziaee; Katharina Strege; Miriam Groß; Carla Vazquez Amos; Mohammad Shahrooei; Parisa Ashournia; Anahita Razaghian; Gillian M Griffiths; Stephan Ehl; Mitsunori Fukuda; Nima Parvaneh
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

8.  Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice.

Authors:  Jana Pachlopnik Schmid; Chen-H Ho; Fabrice Chrétien; Juliette M Lefebvre; Gérard Pivert; Marie Kosco-Vilbois; Walter Ferlin; Frédéric Geissmann; Alain Fischer; Geneviève de Saint Basile
Journal:  EMBO Mol Med       Date:  2009-05       Impact factor: 12.137

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.